Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase III NEPTUNO study of plitidepsin in COVID-19 receives authorization in Spain

April 30, 2021

First clinical trial evaluating intravesical bacteriophage therapy for the treatment of UTIs

April 30, 2021

Analysis of immunological and inflammatory factors associated with COVID-19 severity and progression

April 30, 2021

Atea initiates phase III MORNINGSKY trial of AT-527 in mild or moderate COVID-19

April 29, 2021

Evaluation of cenicriviroc in I-SPY COVID study ended for futility

April 29, 2021

New antiviral compounds discovered at Enanta Pharmaceuticals

April 29, 2021

Enrollment starts in phase II/III study of BI-767551 in mild to moderate COVID-19

April 29, 2021

Veyonda may prevent cytokine storm in moderately severe COVID-19

April 28, 2021

FYB-207 advancing towards clinical trials for COVID-19 in fourth quarter

April 27, 2021

Acylaminooxadiazoles inhibit trans-translation and show in vivo efficacy against N. gonorrhoeae

April 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...